Chikungunya Virus-Like Particle Vaccine Reply

被引：0
|
作者：
Chen, Grace L. [1 ]
机构：
[1] NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 324卷 / 10期
关键词：
D O I：
10.1001/jama.2020.11859
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1008 / 1009
页数：19
相关论文
共 50 条
  • [21] Virus-like Particle Vaccines and Platforms for Vaccine Development
    Kheirvari, Milad
    Liu, Hong
    Tumban, Ebenezer
    VIRUSES-BASEL, 2023, 15 (05):
  • [22] Mucosal Adjuvants for Influenza Virus-Like Particle Vaccine
    Quan, Fu-Shi
    Ko, Eun-Ju
    Kwon, Young-Man
    Joo, Kyoung Hwan
    Compans, Richard W.
    Kang, Sang-Moo
    VIRAL IMMUNOLOGY, 2013, 26 (06) : 385 - 395
  • [23] Characterization of Chikungunya Virus-Like Particles
    Noranate, Nitchakarn
    Takeda, Naokazu
    Chetanachan, Prukswan
    Sittisaman, Pathompong
    A-nuegoonpipat, Atchareeya
    Anantapreecha, Surapee
    PLOS ONE, 2014, 9 (09):
  • [24] Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines
    Rothen, Dominik A.
    Dutta, Sudip Kumar
    Krenger, Pascal S.
    Pardini, Alessandro
    Vogt, Anne-Cathrine S.
    Josi, Romano
    Lieknina, Ilva
    Osterhaus, Albert D. M. E.
    Mohsen, Mona O.
    Vogel, Monique
    Martina, Byron
    Tars, Kaspars
    Bachmann, Martin F.
    VACCINES, 2024, 12 (09)
  • [25] Chikungunya Virus-Like Particle Vaccine (VLP) is highly immunogenic and protects cynomolgus macaques against virus replication and joint disease
    Van Rompay, Koen
    Coffey, Lark
    Olstad, Katherine
    Reader, J. Rachel
    Watanabe, Jennifer
    Usachenko, Jodie
    Weiss, Christopher
    Singapuri, Anil
    Sammak, Rebecca
    Immareddy, Ramya
    Vang, Lo
    Morello, Chris
    Alexander, Jeff
    Manayani, Darly
    Warfield, Kelly
    Anantha, Ravi
    JOURNAL OF MEDICAL PRIMATOLOGY, 2022, 51 (05) : 299 - 299
  • [26] Subunit and Virus-Like Particle Vaccine Approaches for Respiratory Syncytial Virus
    Morrison, Trudy G.
    Walsh, Edward E.
    CHALLENGES AND OPPORTUNITIES FOR RESPIRATORY SYNCYTIAL VIRUS VACCINES, 2013, 372 : 285 - 306
  • [27] Immunological implications of diverse production approaches for Chikungunya virus-like particle vaccines
    Thompson, Danielle
    Metz, Stefan W.
    Abad, Carmen
    Beaty, Shannon
    Warfield, Kelly
    VACCINE, 2022, 40 (22) : 3009 - 3017
  • [28] Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial
    Chang, Lee-Jah
    Dowd, Kimberly A.
    Mendoza, Floreliz H.
    Saunders, Jamie G.
    Sitar, Sandra
    Plummer, Sarah H.
    Yamshchikov, Galina
    Sarwar, Uzma N.
    Hu, Zonghui
    Enama, Mary E.
    Bailer, Robert T.
    Koup, Richard A.
    Schwartz, Richard M.
    Akahata, Wataru
    Nabel, Gary J.
    Mascola, John R.
    Pierson, Theodore C.
    Graham, Barney S.
    Ledgerwood, Julie E.
    LANCET, 2014, 384 (9959): : 2046 - 2052
  • [29] Construction of HIV-1 Virus-like Particle Vaccine
    Zhao Dong-hai
    Zhang Xi-zhen
    Yu Xiang-hui
    Kong Wei
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2008, 24 (05) : 579 - 583
  • [30] Formulation of Microneedles Coated with Influenza Virus-like Particle Vaccine
    Kim, Yeu-Chun
    Quan, Fu-Shi
    Compans, Richard W.
    Kang, Sang-Moo
    Prausnitz, Mark R.
    AAPS PHARMSCITECH, 2010, 11 (03): : 1193 - 1201
12345